Sign in
8-K

Current Report

Prelude Therapeutics Inc Filed Acc 0001564590-22-023674

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading prld-8k_20220617.htm…